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This study focuses on the eﬀect of diﬀerent ﬂexible liposomes containing sodium cholate, Tween 80, or cineol on skin deposition
of carboxyﬂuorescein (CF). Size distribution, morphology, zeta potential, and stability of the prepared vesicles were evaluated. The
inﬂuence of these systems on the skin deposition of CF utilizing rat skin as membrane model was investigated. Results showed that
alloftheinvestigated liposomeshadalmostsphericalshapeswithlowpolydispersity(PDI<0.3)andparticlessizerangefrom83to
175nm. All liposomal formulations exhibited negative zeta potential, good drug entrapment eﬃciency, and stability. In vitro skin
deposition data showed that ﬂexible liposomes gave signiﬁcant deposition of CF on the skin compared to conventional liposomes
and drug solutions. This study revealed that ﬂexible liposomes, containing cineole, were able to deliver higher amount of CF
suggesting that the hydrophilic drugs delivery to the skin was strictly correlated to the vesicle composition.
1.Introduction
The liposomes have been investigated as a systemic carriers
for dermal and transdermal application of drugs [1–5].
Topical delivery of liposomal formulations may have several
advantages over conventional formulations: (a) decreasing
serious side-eﬀects and incompatibilities that may happen
from high systemic absorption of drugs, (b) serving as
penetration enhancers, and (c) serving as a solubilization
matrix [6]. Liposomal carriers have successfully enhanced
the topical application of a number of drugs, including
tretinoin for the treatment of acne [7], glucocorticoids for
the treatment of atopic eczema [8], lignocaine and tetra-
caine as anesthetics [9]. There are several mechanisms that
have been reported in literatures, explaining the penetra-
tion enhancement activity of liposomes. These include the
vesicles that fragment at the skin surface and the vesicle
componentsthatpenetrateintotheintercellularlipidmatrix,
where they blend with the stratum corneum (SC) lipids,
modifying the lipid lamellae [10, 11]. Another mechanism
reported that intact vesicles could go in the SC due to
the inﬂuence of transepidermal osmotic pressure [12]. Cevc
et al. reported that transdermal applications of conventional
liposomes have not achieved a systemic biological eﬀect[13].
Onlylocalizedorrarelytransdermaleﬀectsofliposomeshave
been observed.
Itwasreportedbyseveralresearchersthatthepenetration
enhancement of the vesicles through the skin depends on
the ﬂexibility of vesicles. Furthermore, liposomes with high
ﬂexible membranes could result in improvement of drug
delivery to the skin as compared to liposomes with rigid
membranes [14, 15]. Recently, sequences of new liposomes
with ﬂexible membranes were developed in order to improve
the dermal or transdermal delivery of drugs, for instance,
liposomes containing edge activators such as sodium cholate
and tween 80 [16–18], that is, the so-called transfersomes
[1, 2, 19]. Edge activators are often single-chain surfactants
that destabilize lipid bilayers of the vesicles and provide
ﬂ e x i b l em e m b r a n e[ 20–22]. It has been observed that trans-
fersomeshavepenetratedtheintactskincarryingtherapeutic2 The Scientiﬁc World Journal
Table 1: Composition of the diﬀerent types of liposomes and PBS control.
Code Lipids/components Particle size(nm) PDI zeta potential
CF-CL Lipoid-S75 10% 115 ±1.1 0.132±0.004 −12.6±0.6
Cholesterol 5%
CF-FL1 Lipoid-S75 83±3.2 0.051±0.003 −26.4±1.1
Sodium cholate 2.8%
CF-FL2 Lipoid-S75 10% 133±1.4 0.083±0.008 −37.4±1.6
Tween 80 2.8%
CF-FL3
Lipoid-S75 10%
175±1.2 0.188±0.025 −65.3±1.5 Cineole 1%
Ethanol 3.3%
PBS control PBS (pH 7.4)
CF-CL: conventional liposomes; CF-FL1: ﬂexible liposomes containing sodium cholate; CF-FL2: ﬂexible liposomes containing tween 80; CF-FL3: ﬂexible
liposomes containing cineole and ethanol; the controls present the PBS solution.
concentrations of drugs eﬃciently [19–22]. Moreover, the
elasticityofvesiclemembranescouldbeachievedbyaddition
of the ethanol to the lipids. These vesicles were called
ethosomes and able to penetrate the skin layers eﬃciently
[23].Nevertheless,duetotheinterdigitationresultofethanol
on lipid bilayers, it was commonly supposed that the vesicles
could not coexist with high concentrations of ethanol [23,
24]. Ethosomes are not plenty suﬃcient to convey the drugs
across the SC. Therefore, a lot of approaches were developed
to achieve the successful topical delivery of the drugs.
Recently, novel vesicles were obtained after incorporation of
ethanol and terpenes into the lipids and highly ﬂexible vesi-
cles were achieved. These vesicles ﬁrstly optimized by Verma
et al. and used for transdermal purpose [25]. The terpenes,
which are constituents of essential oils, have broadly been
usedaspenetrationenhancers.Moreover,terpeneshavebeen
proven due to their low skin irritancy at low concentrations
[26]. Cineole is a terpene and extensively used as permeation
enhancers with both hydrophilic and lipophilic drugs. When
skin is treated with cineol, the existing network of hydrogen
bonds between ceramides may get loose and break since
cineol penetrates the lipid bilayer of the SC [27]. Very
recently, ﬂexible vesicles prepared using 1% cineole were
described as transdermal carrier for systems [5, 28].
Therefore, the aim of this study was to prepare lipid
vesicular systems with a ﬂexible bilayer as skin drug delivery
of CF as hydrophilic model drug. Usually, hydrophilic drugs
are characterized by relatively poor skin penetration [29].
For this reason, three diﬀerent types of ﬂexible liposomes
containing sodium cholate, Tween 80, and cineol were
prepared. A further objective of this study is to obtain a
deeper understanding about the mechanism of the action
of the ﬂexible vesicles containing hydrophilic drug on the
skin. Liposomes were characterized in terms of particles
size, zeta potential, stability, and morphology. Penetration
experiments were conducted in order to investigate the
penetration ability of these vesicles.
2.MaterialsandMethods
2.1. Materials. Soybean lecithin Lipoid S75 (Lipoid KG,
Germany). 1, 8-cineole was purchased from Sigma Aldrich
(Taufkirchen, Germany). Sodium cholate (Serva, Germany).
Tween 80 was purchased from Sigma Aldrich (Taufkirchen,
Germany). 5(6)-Carboxyﬂuorescein was purchased from
Sigma-Aldrich, (Steinheim, Germany). Methanol (HPLC
grade) was purchased from Carl Roth GmbH&Co. (Ger-
many). Ethanol, purity≥99.8%, was purchased from Carl
Roth GmbH&Co. (Germany). Phosphate-buﬀered saline
pH=7.4 was composed of 136.89mM NaCl, 2.68mM KCl,
1.47mMKH2PO4 and8.20mMNa2HPO4×2H 2O(allfr o m
Merck, Darmstadt, Germany).
2.2. Preparation of Diﬀerent Types of Liposomes. The lipo-
somes were prepared by a conventional rotary evaporation
method [30]. The lipoids S75, cholesterol, sodium cholate,
or tween 80 were used (to get the optimum ﬂexibility
of the liposomes, weight ratio of surfactant and lipids
should be equal to 0.28) [12, 31, 32]. Brieﬂy, the lipids
and other components (shown in Table 1) were added in a
round bottom ﬂask as solution in organic solvent, chloro-
form/methanol (1:1). The ﬂask was connected to a rotor
evaporator (Rotavapor, B¨ uchi, Germany) and immersed in
a water bath preheated at temperature equal to or more than
the transition temperature of phospholipids that in the case
of lipoid S75 is about 45◦C. The lipid ﬁlm was then ﬂashed
with nitrogen gas for removal of possible traces of organic
solvents. Multilamellar vesicles (MLVs) were formed after
ﬁlm hydration with PBS pH 7.4 containing 20mM CF. These
MLVs were extruded through polycarbonate membranes
[33] with pore size of 100nm by means of the Avestin-
Liposofast device to get liposomes of the preferred size [34].
The liposomes with the cineole were prepared by ethanol
dissolution method [35]. The composition of the liposomes
containing cineole is represented in Table 1. The liposomes
werepreparedbydissolving1%w/vofcineolintheethanolic
solution of lipoid S75. The mixture was vortexed for 5min
and afterwards sonicated for 5min in order to obtain a
clear solution. The PBS ph 7.4 containing 20mM CF was
added to the solution by a syringe under constant vortexing.
The vortexing was continued for additional 5min. The
last step was the extrusion of MLVs through polycarbonate
membranes as described before.
The CF aqueous solution was prepared for comparison
with vesicles system.The Scientiﬁc World Journal 3
2.3. Separation of Free CF from Liposomes. The free CF
was separated from entrapped by using ultracentrifuga-
tion technique (Optima Max-E, Ultra Centrifuge, Beckman
Coulter, Pasadena, CA) at 50,000rpm at 4◦C, for 30min
[36]. Liposome samples were removed when the PBS was
clear. Puriﬁed sediment was then diluted to the initial
volume using PBS (pH=7.4) in order to keep a ﬁnal lipid
concentration of 10%(w/v) and used directly for in vitro
penetration study.
2.4. Physical Characterization of the Dispersions
2.4.1. Particle Size and Zeta Potential Measurements. Photon
correlation spectroscopy (PCS): dynamic light scattering was
measured at 25◦C with a Zeta plus instrument (Brookhaven
Instruments, Brookhaven, USA). The samples were analyzed
24h after preparation. The liposomes were appropriately
diluted with the aqueous phase of the formulations prior
to the measurements. The particle size values given are
the averages of 4 measurements and are expressed as z-
average. The polydispersity index (PDI) measures the size
distribution of the liposomes. Zeta-potential (mV) was
measured by the instrument from electrophoretic mobility
of the particles [37].
2.4.2. Determination of CF-Entrapment Eﬃciency. Free CF
was separated from entrapped using ultracentrifugation
methodasdescribedbefore.ThecontentofCFwasmeasured
by ﬂuorescence spectroscopy, excitation 485nm, emission
520nm. Entrapment eﬃciency of CF was calculated indi-
rectly from the amount of free drug, according to the
following equation:
Entrapment eﬃciency (%) =

CFt-CFf
CFt

×100, (1)
where CFf was the amount of free CF and CFt was the total
amount of CF.
2.4.3. Storage Stability Studies. In order to determine the
physical stability of vesicles, the vesicles were stored at
4◦C for up to 2 months under light protection [38]. In
predetermined time intervals, the particle sizes of the vesicles
and PDI were measured.
2.4.4. Transmission Electron Microscopy. The shape and
lamellarity of the diﬀerent liposomal dispersions were inves-
tigated by cryoelectron microscopy (Cryo-TEM). Five µLo f
the dispersions were put onto a perforated coated net of
copper (Quantifoil R 1.2/1.3, 400mesh). Excess of samples
were removed with a sheet of ﬁlter paper. The samples were
quickly frozen with liquid ethane (−170 to −180◦C) in a
cryo-box (Carl Zeiss NTS GmbH). Excess of ethane was
removed by blotting the samples in the cold and the samples
were placed with the help of a cryo-holder (Gatan 626
SingleTiltCryotransferSystem)inaprecooledtransmission-
cryo-electron microscope (Philips CM 120). Microscopy was
performed at 120kV and viewed under low-dose conditions.
2.4.5. In Vitro Penetration Studies. The abdominal hair of
male Wistar rat skin was removed with an electric clipper
carefully. After the rats were scariﬁed, the subcutaneous fat
tissue was carefully removed from the skin using a scalpel
and surgical scissors. Afterwards, the skin was wrapped into
aluminum foil and stored at −20◦C until use. Prior to the
experiments, the skin samples were taken from the freezer
a n dl e tt h a wa tr o o mt e m p e r a t u r ef o ra b o u t3 0m i n .A f t e r
thawing, the skin surface was carefully wiped with cotton
wool balls wetted with PBS buﬀer. All procedures were
approved by Institutional Animal Care and Use Committee
and were conducted in accordance with the NIH Guidelines
for the Care and Use of Laboratory Animals.
Skin samples were mounted onto Franz diﬀusion cells
(FDCs) with a nominal area for diﬀusion of 1.76cm2 and a
r e c e p t o rv o l u m eo fa b o u t1 2m L .T h ee p i d e r m a ls i d eo ft h e
skin was exposed to ambient conditions while the dermal
side was bathed with BPS buﬀer pH 7.4. The receptor
ﬂuid was kept at 37±1◦C throughout the experiments to
reach the physiological skin temperature (i.e., 32±1◦C).
The constant stirring was maintained by magnetic stirring
at 500rpm. Care was taken to remove all air bubbles
between the underside of the skin (dermis) and the receptor
solution throughout the experiment. After equilibration for
30min, 10µL/cm2 of liposomal dispersions or PB solution
containing CF were applied to the skin surface. Samples were
taken from the receptor ﬂuid (500µL) every hour and the
withdrawn volume was replaced by the same volume of fresh
PBS pH 7.4 to maintain a constant volume. After 6h, the
formulations were wiped oﬀ by the cotton wool pads wetted
with PBS buﬀer 3-4 times.
Fordeterminationsofthedrugdepositioninthediﬀerent
skin layers, the skin was ﬁxed onto cork plates and stretched
using small pins. The SC was then subsequently removed by
tape stripping. Transpore tape (3M TransporeTM tape, St.
Paul, MN, USA) with a surface area of approximately 4cm2
wasappliedontheSCsurfaceoftheskin.Thetapewasﬁrmly
pressed on skin surface and pulled oﬀ immediately with one
smooth stroke. Each skin sample was stripped with 10 pieces
of adhesive tape to conﬁrm the removal of the SC [39, 40].
The amount of CF in the stripped skin was determined by
cuttingintosmallpieces.Thetapes,strippedskinwereplaced
each in PBS pH=7.4:ethanol (2:1) overnight followed
by 5min vortexing and 5min sonication for complete
extraction of CF followed by ﬁltration. The tapes, stripped
skin, and receptor ﬂuid were assayed for the content of CF
by ﬂuorescence spectroscopy, excitation 485nm, emission
520nm [5]. All experiments were done in triplicate. The
extraction method was validated by spiking with a known
amount of theCF. The recoveries wereabout 90% fromtapes
and stripped skin.
3. Results and Discussion
3.1. Particle Size Measurement. In the present study, three
diﬀerent ﬂexible liposomes containing sodium cholate,
Tween 80, and cineol were prepared to overcome the SC
barrierproperties.TheadditionofsuchsurfactantsTween80
andsodiumcholateinvesiclemembranesleadtoﬂexibilityof4 The Scientiﬁc World Journal
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Figure 1: The entrapment eﬃciency of carboxyﬂuorescein- (CF-) loaded diﬀerent liposomes: (CF-CL: conventional liposomes; CF-FL1:
ﬂexibleliposomescontainingsodiumcholate;CF-FL2:ﬂexibleliposomescontainingtween80;CF-FL3:ﬂexibleliposomescontainingcineole
and ethanol.)
the vesicles membrane [40, 41]. Also, cineole is widely used
toprepare ﬂexible liposomes [5].Recently,ﬂexible liposomes
prepared using 1% cineole as penetration enhancers with
both hydrophilic and lipophilic drugs were developed [5,
42, 43]. For the eﬃciency of these ﬂexible vesicles on
delivering CF, a hydrophilic model drug through rat skin
wasinvestigatedandcomparedwithanaqueoussolutionand
conventional liposomes. The compositions of these diﬀerent
vesicular systems, their particle size distribution, PDI, and
zeta potential are presented in Table 1.
Particle size of the formulated vesicles after extruded
through 100nm polycarbonate membrane is presented in
Table 1. The results showed that the average size of ﬂexible
liposomes containing Tween 80 (CF-FL2) was 133nm with a
PDI of 0.083 while, the average size of the ﬂexible liposomes
containing sodium cholate (CF-FL1) was 83nm with a PDI
of 0.051. The increasing of particle size of CF-FL2 may be
due to that Tween 80 is considered as a nonionic surfactant
while sodium cholate is anionic surfactants, so it had a
morenegativezetapotentialleadingtorepulsionbetweenthe
bilayers, so, an enlarge of the particle size of these vesicles
was observed [44, 45]. In case of vesicles containing cineole
and ethanol, a slight increase in the vesicle size (175nm) was
detected. The increase of the vesicle size of CF-FL3 could
be attributed to presence of ethanol and cineole, which can
impart negative charge and destabilize the lipid bilayer of
the vesicle, which lead to an increase of the particle size.
Thisﬁndingisinagreementwithpreviousstudy(Dragicevic-
Curic et al. [42]). The particle size of conventional liposomes
was 115nm. The PDI of the investigated formulations was
below 0.3, which indicates the homogeneity of the prepared
CF-loaded liposomes [5, 25, 28, 42, 46].
Regarding the zeta potential measurements,allliposomal
dispersions had a negative surface charge, indicating that
the formulations are more stable and homogeneous distri-
bution (Table 1). Liposomes containing Tween 80 had more
negativity than sodium cholate. The reason for this result is
that Tween 80 is a nonionic surfactant while sodium cholate
is anionic surfactant [45]. Lee et al. revealed that Tween
80 transfersomes have a more negative zeta potential than
sodium cholate. The surface charge of liposomes containing
cineol recorded −6 5 m V .T h i sh i g hn e g a t i v ec h a r g ev a l u e
of these liposomes is attributed to the presence of ethanol.
Ethanol was found to increase negativity of the liposomes
[24].
3.2. Entrapment Eﬃciency (EE %). The entrapment eﬃ-
ciency of CF in ﬂexible liposomes CF-FL1, CF-FL2, and CF-
FL3 reported, 41.7, 52.2, and 66.7% respectively, compared
with 25.3% reported for conventional liposomes CF-CL
(Figure 1). It is obvious that CF-FL3 represented the largest
EE% which is accompanied with increasing the particle size
and zeta potential of the vesicles. A number of studies found
that presence of ethanol and cineole increased the size of
the vesicles and the zeta potential of liposomes [5, 28, 34,
35, 43]. The reason for that was attributed to the high
value of zeta potential which frequently leads to increasing
the repulsion forces of the bilayer structure of the vesicles
which consequently increases the size of the inner aqueous
core of the liposomes. Being CF, hydrophilic compound,
increasing the size of aqueous core compartment contributes
inincreasingtheamountofCFinthevesiclesasitisobserved
in this study.
Comparing the EE% of CF-FL1 and CF-FL2, the EE%
of CF-FL2 was higher than that of CF-FL1 which is in
agreement with other studies [43, 44, 47]. These studies
suggested that diﬀerences in HLB of these surfactants may
have certain impact in these ﬁndings in which the aﬃnity of
surfactants towards lipids would be inversely proportional to
HLB value.
Although lower EE% is to be predictable for hydrophilic
drugs, the high EE% values of such hydrophilic model in the
ﬂexible liposomes as presented in Figure 1 prove the success
of the preparation method as such type of drug is expected
to be restricted in the aqueous compartment of lipid vesicles
[48]. The thin ﬁlm-technique is supposed to get better ofThe Scientiﬁc World Journal 5
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Figure 2: Stability study of CF-loaded liposomal dispersions stored at 4◦C over 2months duration. (a) Change of particle size (z-average),
(b) change of the polydispersity index (PDI).
the entrapment of hydrophilic drugs, due to formation of a
thin-ﬁlm with large surface area which enables the complete
hydration of the vesicles [49], which is obvious in the present
study.
3.3. Stability Studies. The physical stability of the conven-
tional and ﬂexible liposomes stored at 4◦Cf o r6 0 d a y sa r e
presented in Figure 2. The stability results showed that a
minimal eﬀect on particle size and PDI of the investigated
liposomes was noticed. The particle size and the PDI of
diﬀerentliposomal dispersion have slightly increasedafter60
days storage, Figures 2(a) and 2(b).
3.4. Transmission Electron Microscopy. Cryo-TEM is a useful
tool to identify the shapes of the vesicles. In this study,
CF-loaded liposomes were mostly unilamellar (Figures 3(a),
3(b), 3(c) and 3(d) black short arrows) and bilamellar
(Figures 3(b) and 3(d), white length arrows); spherical in
shape;however,vesiclesofirregularshapeswerealsodetected
(Figures 3(b), 3(c) and 3(d), white short arrow).
In more details, conventional liposomes showed homo-
geneity in size with unilamellar liposomes, also the vesicles
seem to be inﬂexible (Figure 3(a)). In case of CF-FL1, CF-
FL2, and CF-FL3 (Figure 3(b), 3(c) and 3(d)) vesicle shapes
showed homogeneity in size. These vesicles seem to be
ﬂexible in comparison with conventional liposomes. These
vesicles were mostly unilamellar and bilamellar, however,
vesicles of irregular shape were also detected which depart
from the sphere-shaped vesicles. Flexibility of these vesicles
could be as a reason of the presence of cineol or edge
activators (Tween 80 and Sod. Cholate) within the vesicles
membrane. Presence of these compounds leads to increase
deformability of the membrane (i.e., ﬂexibility). Regard-
ing liposomes containing cineole and ethanol, the vesicles
appeared to be oval in shape and vesicles with irregular
shapes were also seen. It is reported that the incorporation
of cineole into the vesicles resulted in high membrane
ﬂexibility of the vesicles [28]. In addition, the liposomes
with sodium cholate had lower ﬂexibility than tween 80,
due to the steroid-like structures which are bulkier than
the hydrocarbon chains of Tween 80. This could be a result
of their high hydrophobicity which leads to diminish the
formation of transient hydrophilic holes, hence, minimizing
the amphiphilic character of the bilayers responsible for
membrane ﬂuidity (ﬂexibility) [44].
Diﬀerent studies showed that the ﬂexibility of liposomes
is an important factor in the skin penetration in which
moreﬂexibleliposomesenhanceddrugdeliverythroughskin
in more magnitude compared with conventional liposomes
[20, 21, 50].
3.5. In Vitro Penetration Studies. I no r d e rt oi n v e s t i g a t e
the ability of ﬂexible vesicular systems to enhance drug
deposition into the skin layers, the penetration of CF-
loadedﬂexibleliposomesandtherespectivePBSsolutionwas
studiedandcomparedwithconventional liposomes(Table 2,
Figure 4). CF was used as hydrophilic label because a poor
penetration through the skin by passive diﬀusion of such
hydrophilic compound can be expected [51].
After incubation of the skin with the CF solution for 6
hours, only small amounts of CF were found in the SC, the
stripped skin and the CF were not detected in the receptor
ﬂuid. When the skin was treated with the vesicular systems,
particular amount of CF in the receptor ﬂuid was detected
(Figure 4). This indicates that the vesicles play an important
role in the delivery of the drug into the skin layer [46].
Otherwise, the application of CF-CL revealed a deﬁnitely
improveddeliveryofCFintoandthroughtheskincompared6 The Scientiﬁc World Journal
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Figure 3: Visualization of CF-loaded liposomes by cryo-electron microscopy. (a) CF-CL, (b) CF-FL1, (c) CF-FL2, and (d) CF-FL3. Black
short arrows represent unilamellar vesicles; black arrows of length represent multilamellar vesicles, white short arrows represent deformed
vesicles while white long arrows represent bilamellar vesicles.
Table 2: Amounts of CF (expressed as cumulative % of dose applied, n = 3) in the diﬀerent layers of rat skin after 6 hours of nonocclusive
incubation.
Code SC Stripped Skin Receptor Total
CF-CL 0.93 ± 0.45 0.12 ±0.05 0.03 ±0.01 1.08 ± 0.17
CF-FL1 3.61 ±0.23 0.55 ±0.17 0.29 ±0.05 4.45 ± 0.23
CF-FL2 4.12 ±0.19 0.31 ±0.05 0.18 ±0.03 4.61 ± 0.15
CF-FL3 7.36 ±0.13 0.34 ±0.13 0.14 ±0.02 7.85 ± 0.09
PBS control 0.35 ±0.11 0.03 ±0.01 not detectable 0.38 ± 0.04
to the CF solution. The amount of CF in the SC and in
the stripped skin was 2.7 and 4-fold higher for the CF-CL
compared to the CF solution. Furthermore, a small amount
of CF was found in the receptor ﬂuid (Table 2, Figure 4).
Moreover, the application of ﬂexible liposomes resulted
in a further increase in the amount of CF within the skin
layers as well as in the receptor ﬂuid compared to con-
ventional liposomes (Table 2, Figure 4). The incubation of
skin with CF-FL3 showed the highest amount of CF in the
SC (8-fold) and in the stripped skin (3-fold) as well as in
the receptor ﬂuid (4.6-fold) compared to conventional lipo-
somes. CF-FL1 and CF-FL2, CF deposition into deeper skinThe Scientiﬁc World Journal 7
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Figure 4: Amount of CF delivered into the SC, Stripped skin
and the receptor ﬂuid after 6h of incubation with rat skin (CF-
CL: conventional liposomes; CF-FL1: ﬂexible liposomes containing
sodium cholate; CF-FL2: ﬂexible liposomes containing tween 80;
CF-FL3: ﬂexible liposomes containing cineole and ethanol. The
controls present the PBS solution).
layers(strippedskin)andthereceptorﬂuidwerepronounced
but CF amounts in the SC were reduced (Table 2, Figure 4).
Compared to the conventional liposomes, CF-FL1 and CF-
FL2 showed an increase in the amounts of CF by 3.8- and
4.4-fold in the SC, 4.5 and 2.6-fold in the stripped skin, 9.6-
and 6-fold in the receptor ﬂuid, respectively. These results
were in agreement with other studies using ﬂexible vesicles
containing Tween 80 or sodium cholate as a transdermal
carrier systems [40, 50].
Interestingly,theamountofCFinthediﬀerentskinlayers
after skin incubation with the aforementioned liposomal
formulations (CF-FL1, CF-FL2, CF-FL3, and CF-CL) was
varied indicating the signiﬁcant impact of liposomal compo-
sition on the percutaneous absorption of compounds. These
data revealed that ﬂexible vesicles were able to deliver the
encapsulated hydrophilic model drug into the receptor ﬂuid
in an amount more than that of solution [50].
Concerning the enhancement deposition of CF as a
hydrophilic model drug, CF-FL3 showed higher deposition
of CF in the SC than conventional liposomes and other
ﬂexible liposomes investigated in this study, indicating a
potentialeﬀectofcineoleandethanolinthedrugdeposition.
These results are in agreement with results reported by other
authors who proposed that ethanol and phospholipids as
well as terpenes (e.g., cineole) have a synergistic eﬀect on
ﬂuidizing the intercellular SC lipids, which lead to enhanced
drug deposition [3, 5, 25, 28, 35, 42]. Moreover, ethanol
is attributed to ﬂuidize the intercellular lipids of SC [52].
Ethanol and cineole have ability to produce ﬂexible vesicles,
which was shown by the presence of irregular shape of
vesicles using cryoelectron microscopy (Figure 3(d)). Due to
the ﬂexibility of the vesicle bilayer, penetration into the SC
maybefacilitatedparticularlyundernonocclusiveconditions
and driven by the existence of the transepidermal osmotic
gradient allowing vesicles to squeeze and migrate as intact
into the SC [25, 35]. Furthermore, ethanol and cineol may
also act as penetration enhancer by disturbing the SC lipid
structure [53, 54].
By comparing the deposition data of ﬂexible liposomes
containing Tween 80 or cholate to conventional liposomes,
it is clear that the deposition of CF is high in the SC and
deeper layers after application of ﬂexible liposomes. Alter-
native studies proposed mechanisms that may explain the
enhancement power of ﬂexible liposomes. These proposed
mechanisms include the ability of liposome to work as
drug carrier systems, in which intact vesicles transported the
stratumcorneumcarryingdrugintotheskin.Anothermech-
anism stated that vesicles can act as penetration promoters,
in which vesicle bilayers interact with the stratum corneum
causing modiﬁcation in the intercellular lipid lamellae. This
eﬀect will facilitate the partitioning of the drug molecule
into and penetration through the stratum corneum [20–22].
Regarding the lower deposition of CF in the SC in presence
of sodium cholate, this may be due to that sodium cholate
has higher HLB (16.7) than Tween 80 (15); as a result, the
aﬃnityofTween80towardslipidsisexpectedtobehigh[15].
Therefore, after transdermal application of these vesicles,
they follow local transdermal hydration gradient, hence, the
highest CF deposition in the SC could be observed with
Tween 80. A number of studies found that ﬂexible liposomes
in presence of Tween 80 increased the drug ﬂux as compared
to conventional liposomes [14, 15, 17].
Drug deposition in the diﬀerent skin layers was depen-
dent on the compositions of ﬂexible liposomes. Skin incu-
bation with liposomes containing cineole and ethanol led to
thehighestdrugdepositionintheSCcomparedtoliposomes
containing Tween 80 or cholate.
3.5.1. Conclusion. In the present study, the ﬂexible vesicular
systems containing a hydrophilic model drug, CF along with
conventional liposomes, were developed and characterized.
Flexible liposomes were able to enhance the delivery of CF
through skin. The highest amount of CF was deposited into
the SC by ﬂexible liposomes containing cineole and ethanol.
However, the highest amount of CF was delivered to the
deeper layers of the skin and receptor ﬂuid was detected by
ﬂexible liposomes containing sodium cholate. The results of
thedepositionstudyrevealedthatﬂexibleliposomeswerethe
most eﬀective in delivering the hydrophilic model drugs into
the SC and skin layers. The ﬂexible vesicles incorporating
cineole and ethanol when applied nonocclusively onto rat
skin signiﬁcantly increased distribution of CF in the SC
compared with conventional liposomes.
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